ABSTRACT
Secretory carcinoma is a rare, recently identified and recognized neoplasm in major salivary glands. Few cases have been described with only 16 pediatric cases in the literature. We present a case preoperatively identified as a benign parotid lesion whose management was delayed due to the COVID-19 pandemic. Post enucleation of the lesion, histology identified a secretory carcinoma. This led to further and more extensive surgery to ensure complete removal. Clinicians and histopathologists should be aware of secretory carcinoma in their differential, as a high index of suspicion is required to ensure appropriate investigations are performed to obtain the diagnosis. Early identification is important to allow timely appropriate surgery to be performed.
ABSTRACT
Purpose of Review: To summarise the current understanding of post-infectious olfactory dysfunction (PIOD) and provide a consensus on management of the condition through an evidence-based approach, critically reviewing the available management options. Recent Findings: New studies investigating the pathophysiology of PIOD in COVID-19 patients have found that in those with persistent symptoms there is an association with lower tissue perfusion in the orbital and medial regions of the frontal lobe. Recent meta-analyses have listed olfactory training as the first line management for PIOD. Summary: Olfactory training remains the most recommended management option for PIOD. The use of systemic corticosteroids to treat PIOD is not encouraged due to poor evidence.